- Home
- SLRX
as of 12-12-2025 2:43pm EST
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 3.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 664.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -33.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.71 - $108.00 | Next Earning Date: | 11-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AI-Powered SLRX Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Salarius Pharmaceuticals Inc. (SLRX)
Director
Avg Cost/Share
$0.75
Shares
5,000
Total Value
$3,740.50
Owned After
5,015
SEC Form 4
Exec VP Finance, CFO
Avg Cost/Share
$0.80
Shares
20,000
Total Value
$16,000.00
Owned After
20,177
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HANISH ARNOLD C | SLRX | Director | Nov 20, 2025 | Buy | $0.75 | 5,000 | $3,740.50 | 5,015 | |
| Rosenblum Mark J | SLRX | Exec VP Finance, CFO | Nov 20, 2025 | Buy | $0.80 | 20,000 | $16,000.00 | 20,177 |
Compare SLRX vs Leading Stocks
See how SLRX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SLRX Salarius Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.